Skip to content

Extubation Criteria in Patients Greater Than 59 Years of Age

A Prospective Evaluation of Extubation Criteria in Patients Greater Than 59 Years of Age Following Anesthesia and Non-cardiac Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04596735
Enrollment
4000
Registered
2020-10-22
Start date
2020-10-16
Completion date
2025-08-21
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extubation, Respiratory Complications

Keywords

non-cardiac surgery, non-thoracic surgery, reintubation

Brief summary

Prospectively evaluate the predictive value of individual pre-specified clinical extubation criteria for extubation success

Detailed description

Perform a prospective observational study to evaluate routine criteria commonly used to extubate elderly patients in the operating room after non-cardiac and non-thoracic surgery to ultimately reduce the incidence of near-term reintubation and by extension other respiratory complications

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>= 60 years of age * Patients undergoing general endotracheal anesthesia for surgery or invasive diagnostic procedures that are anticipated to be extubated immediately following the procedure

Exclusion criteria

* Age\<60 years of age * Patients with a tracheostomy in - situ (pre-existing or placed as part of the index procedure) * Patients undergoing cardiac surgical procedures * Patients undergoing general endotracheal anesthesia who are not anticipated to be extubated immediately following the surgical procedure * Patients with delayed extubations in the post anesthesia care unit or intensive care unit) * Patients undergoing TIVA (Total Intravenous Anaesthesia) * Patient with an initial room air SpO2\<93% * Patients with VADS (ventricular assist device) undergoing non-cardiac surgery * Thoracic surgical procedures * Patients on home oxygen * Patients getting general anesthesia with supraglottic airway

Design outcomes

Primary

MeasureTime frameDescription
Extubation Success or Extubation requiring InterventionDay 1Quality of extubation will be assessed using a standard rubric for all extubation.
Presence or Absence of specific extubation criteria.Day 1Assess the presence of specific extubation criteria met during extubation from the following list: Following Commands, Tidal volume\>4 cc/kg, Conjugate gaze, End-tidal CO2 (ETCO2) \<55 mmHg, ET agent concentration \< (Des 1%, Iso \<=0.2%, Sevo \<0.3%, oxygen saturation (SpO2) \> 94%,Qualitative or quantitative Tetralogy of Fallot (TOF), Purposeful Movement, 5 second head lift, Spontaneous Respiratory Rate \>=8 bpm at extubation, eye opening

Secondary

MeasureTime frameDescription
Number of Participants with Preoperative Exposures (COPD) Chronic obstructive pulmonary diseasePreoperativepresence of COPD
Number of Participants with Preoperative Exposures (Dementia)Preoperativepresence of dementia
Number of Participants with Preoperative Exposures (obstructive sleep apnea by history or STOP BANG) (snoring, tiredness, observed apnea, blood pressure, body mass index, age, neck circumference and gender)Preoperativeobstructive sleep apnea SCORE \>3
Number of Participants with Preoperative Exposures (Sleep Disordered breathing by history or STOP BANG) (snoring, tiredness, observed apnea, blood pressure, body mass index, age, neck circumference and gender)PreoperativeSTOP BANG SCORE \>3
Number of Participants with Preoperative Exposures (Neuro-degenerative disorders)PreoperativeNeuro-degenerative disorders such as: amyotrophic lateral sclerosis, Parkinson's, multiple sclerosis, Alzheimer's, Huntington's
Number of Participants with Preoperative Exposures (Heart failure)Preoperativeby history or documented echo
Number of Participants with Preoperative Exposures (Opioid naïve)Preoperativeby history or from electronic health record
Number of Participants with Preoperative Exposures (Diabetes)Preoperativepresence of diabetes mellitus
Number of Participants with Preoperative Exposures (ESRD) End-Stage Renal DiseasePreoperativepresence of end-stage renal disease
Number of Participants with Preoperative Exposures (CVA) cerebrovascular accident - medical term for a strokePreoperative
Number of Participants with Preoperative Exposures (Chronic Restrictive Lung disease)Preoperative
Number of Participants with Preoperative Exposures (Current Smoker)Preoperativecurrent smoker or \>=20 year pack history
Number of Participants with Preoperative Exposures (Inhalational agent used for maintenance)PreoperativeAnesthetic maintenance agent used at time of extubation
Number of Participants with Preoperative Exposures (Use of (NMB) Neuromuscular Blockerduring procedure
Number of Participants with Preoperative Exposures (Use of Midazolam)during procedure
Number of Participants with Preoperative Exposures (Use of opioid agonist during preoperative or intraoperative phase)during procedure
Number of Participants with Preoperative Exposures (Regional Anesthesia other than local infiltration)during procedure
Number of Participants with Preoperative Exposures (Type of inhalational agent used for maintenance)during procedureQualitative measures will be used to analyze this Outcome Measure
Number of Participants with Preoperative Exposures (Use of train of 4 monitoring)during procedureA peripheral nerve stimulator, also known as a train-of-four monitor, is used to assess neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity
Number of Participants with Preoperative Exposures (Use of Sugammadex for reversal)during procedure
Number of Participants with Preoperative Exposures (Use of Neostigmine for reversal)during procedure
Anesthesia Time during procedureduring procedure
Number of Participants with Preoperative Exposures (Difficult Airway)during procedureDifficult Airway or use of alternative airway technique other than DL because of suspected difficulty with the airway
Number of Participants with Preoperative Exposures (Intracranial Procedure)during procedure
Number of Participants with Preoperative Exposures (positive end-expiratory pressure (PEEP)during procedure(PEEP) positive end-expiratory pressure \>7 cmH2O for \>10 minutes
Number of Participants with Preoperative Exposures (Surgical Procedure)during procedure
Number of Participants with Preoperative Exposures (Open Abdominal)during procedure
Number of Participants with Preoperative Exposures (Laparoscopic or Robotic Procedure)during procedure
IV fluid volumeduring procedure
volume of blood productsduring procedure
types of blood productsduring procedure
Number of Participants with Preoperative Exposures (use of colloid)during procedure
volume of colloidduring procedure
Number of Participants with Preoperative Exposures (Use of blood or other blood products such as platelets, FFP(Fresh frozen plasma), or Cryo)during procedure
Number of Participants with Preoperative Exposures (ASA) American Society of Anesthesiologists Emergency StatusPreoperativeThe classification system alone does not predict the perioperative risks, but used with other factors (eg, type of surgery, frailty, level of deconditioning), it can be helpful in predicting perioperative risks

Other

MeasureTime frameDescription
Hospital stayday 60length of stay
30 day Mortality Rateday 3030 Day mortality obtained from the chart in order to determine association with intervention required at extubation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026